日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

帕博利珠单抗联合化疗治疗晚期或复发性子宫内膜癌:NRG GY018 3期随机试验的总生存期和探索性分析

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert S; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Lokich, Elizabeth; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Baghdadi, Tareq Al; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估腹膜恶性细胞学在子宫内膜癌预后中的意义:一项基于 GOG-210 方案的 NRG 肿瘤/妇科肿瘤协作组研究

Matsuo, Koji; Enserro, Danielle M; Wright, Jason D; Roman, Lynda D; Powell, Matthew A; Miller, David S; Nagel, Christa I; Thaker, Premal H; Mannel, Robert S; Stuckey, Ashley R; Guntupalli, Saketh R; Sukumvanich, Paniti; Geller, Melissa A; Vargas, Roberto; Konecny, Gottfried E; Warshal, David P; Tewari, Krishnansu S; Spirtos, Nick M; Pothuri, Bhavana; Creasman, William T; Mutch, David G

Parameter efficient fine-tunning of foundation model to facilitate tumor response prediction for ovarian cancer patients

对基础模型进行参数高效微调,以促进卵巢癌患者肿瘤反应预测

Zhang, Ke; Gilley, Patrik; Abdoli, Neman; Thai, Theresa C; Chen, Yong; Dockery, Lauren; Moore, Kathleen; Mannel, Robert S; Tang, Qinggong; Qiu, Yuchen

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

顺铂、吉西他滨联合调强放射治疗局部晚期外阴鳞状细胞癌的II期临床试验:NRG肿瘤/GOG 279研究

Horowitz, Neil S; Deng, Wei; Peterson, Ivy; Mannel, Robert S; Thompson, Spencer; Lokich, Elizabeth; Myers, Tashanna; Hanjani, Parvis; O'Malley, David M; Chung, Ki Young; Miller, David S; Ueland, Frederick R; Dizon, Don S; Miller, Austin; Mayadev, Jyoti S; Leath, Charles A 3rd; Monk, Bradley J

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

鲁索替尼联合一线新辅助治疗晚期卵巢癌的I期和随机II期研究:NRG肿瘤协作组研究

Landen, Charles N; Buckanovich, Ronald J; Sill, Michael W; Mannel, Robert S; Walker, Joan L; DiSilvestro, Paul A; Mathews, Cara A; Mutch, David G; Hernandez, Marcia L; Martin, Lainie P; Bishop, Erin; Gill, Sarah E; Gordinier, Mary E; Burger, Robert A; Aghajanian, Carol; Liu, Joyce F; Moore, Kathleen N; Bookman, Michael A

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

放射治疗联合或不联合顺铂治疗子宫内膜癌局部复发:NRG肿瘤学/GOG前瞻性随机多中心临床试验结果

Klopp, Ann H; Enserro, Danielle; Powell, Matthew; Randall, Marcus; Schink, Julian C; Mannel, Robert S; Holman, Laura; Bender, David; Kushnir, Christina L; Backes, Floor; Zweizig, Susan L; Waggoner, Steven; Bradley, Kristin A; Lawrence, Lana DeSouza; Hanjani, Parviz; Darus, Christopher J; Small, William Jr; Cardenes, Higinia R; Feddock, Jonathan M; Miller, David S

Developing a novel image marker to predict the clinical outcome of neoadjuvant chemotherapy (NACT) for ovarian cancer patients

开发一种新型影像标志物,用于预测卵巢癌患者新辅助化疗(NACT)的临床疗效

Zhang, Ke; Abdoli, Neman; Gilley, Patrik; Sadri, Youkabed; Chen, Xuxin; Thai, Theresa C; Dockery, Lauren; Moore, Kathleen; Mannel, Robert S; Qiu, Yuchen

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

美国国家癌症研究所国家临床试验网络治疗研究的人口、临床和科学影响

Unger, Joseph M; LeBlanc, Michael; George, Suzanne; Wolmark, Norman; Curran, Walter J Jr; O'Dwyer, Peter J; Schnall, Mitchell D; Mannel, Robert S; Mandrekar, Sumithra J; Gray, Robert J; Zhao, Fengmin; Bah, Mariama; Vaidya, Riha; Blanke, Charles D

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study

一项针对晚期卵巢癌/输卵管癌/腹膜癌女性患者的维持性紫杉烷类药物治疗与监测的III期随机试验:妇科肿瘤协作组0212:NRG肿瘤学研究

Copeland, Larry J; Brady, Mark F; Burger, Robert A; Rodgers, William H; Huang, Helen Q; Cella, David; O'Malley, David M; Street, Daron G; Tewari, Krishnansu S; Bender, David P; Morris, Robert T; Lowery, William J; Miller, David S; Dewdney, Summer B; Spirtos, Nick M; Lele, Shashikant B; Guntupalli, Saketh; Ueland, Frederick R; Glaser, Gretchen E; Mannel, Robert S; DiSaia, Philip J

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study

基于肿瘤内在化疗敏感性识别一线贝伐单抗治疗中获益最大的卵巢癌患者(KELIM):GOG-0218 验证研究

You, Benoit; Purdy, Christopher; Copeland, Larry J; Swisher, Elizabeth M; Bookman, Michael A; Fleming, Gini; Coleman, Robert; Randall, Leslie M; Tewari, Krishnansu S; Monk, Bradley J; Mannel, Robert S; Walker, Joan L; Cappuccini, Fabio; Cohn, David; Muzaffar, Mahvish; Mutch, David; Wahner-Hendrickson, Andrea; Martin, Lainie; Colomban, Olivier; Burger, Robert A